⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 1, 2012Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicineOpen Access

Editorial (End of the Beginning and Public Health Pharmacogenomics: Knowledge in ‘Mode 2’ and P5 Medicine)

Vural Özdemir Erik Fisher Edward S. Dove Hilary Burton Galen E.B. Wright Mario Masellis Louise Warnich

View Full Paper

Ask AI

Bookmark

Share

Abstract

Keywords: Africa, global personalized medicine, knowledge in mode 2, omics biotechnologies, P5 medicine, public health pharmacogenomics, science studies, sociomateriality

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Özdemir et al. (2012) studied this question.

synapsesocial.com/papers/6aa95cd373c59fa727050101 https://doi.org/10.2174/1875692111201010001

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Population Distribution of CES1 Genetic VariantsCurrent pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · Sat,
2Pharmacomicrobiomics: Deciphering the Bidirectional Interplay between Gut Microbiota and Pharmaceuticals for Optimized TherapyCurrent pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · Fri,
3AI-Enabled Personalized Medicine in Lung Cancer: Diagnostics, Prognostics, and Targeted Drug Delivery- A Systematic ReviewCurrent pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · Thu,
4The Intricate Role of Gut Microbiota in Human Health: Mechanismsof Homeostasis, Dysbiosis, and Therapeutic InterventionsCurrent pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · Thu,
5ApoE4 and Alzheimer’s Disease: Glial Cell Dysfunction, Metabolic Crosstalk, and Precision Medicine PerspectivesCurrent pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · Thu,

More from Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine

Tailored Therapeutics: Redefining Pharmaceutical Design in the Age of Personalized MedicineWed,
Therapeutic Potential of Drug Repurposing in Alzheimer’s Disease:Advancing Toward Disease ModificationTue,
Integrative Perspectives on Diabetes Mellitus and the Therapeutic Potential of Horse Chestnut (Aesculus hippocastanum)Thu,
Precision Medicine in Eye Melanoma: Advancing Targeted Therapies and Personalized CareThu,
Corrigendum to: Artificial Intelligence: The New Doctor in Personalized MedicineTue,